These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2282564)

  • 1. Bone changes in hyperthyroidism--a preliminary study.
    Chen ST; Huang MJ; Juang JH; Lin JD; Huang BY; Huang HS; Tzen KY
    Changgeng Yi Xue Za Zhi; 1990 Dec; 13(4):274-81. PubMed ID: 2282564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone mineral density trends in Indian patients with hyperthyroidism--effect of antithyroid therapy.
    Dhanwal DK; Gupta N
    J Assoc Physicians India; 2011 Sep; 59():561-2, 567. PubMed ID: 22334969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone loss in hyperthyroid patients and in former hyperthyroid patients controlled on medical therapy: influence of aetiology and menopause.
    Jódar E; Muñoz-Torres M; Escobar-Jiménez F; Quesada-Charneco M; Lund del Castillo JD
    Clin Endocrinol (Oxf); 1997 Sep; 47(3):279-85. PubMed ID: 9373448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical application of alendronate for osteoporosis/osteopenia secondary to hyperthyroidism].
    Yang LJ; Shen FX; Zheng JC; Zhang HL
    Zhongguo Gu Shang; 2012 Feb; 25(2):133-7. PubMed ID: 22577718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced bone mineral density at diagnosis and bone mineral recovery during treatment in children with Graves' disease.
    Lucidarme N; Ruiz JC; Czernichow P; Léger J
    J Pediatr; 2000 Jul; 137(1):56-62. PubMed ID: 10891822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone mineral density in hyperthyroidism.
    Karga H; Papapetrou PD; Korakovouni A; Papandroulaki F; Polymeris A; Pampouras G
    Clin Endocrinol (Oxf); 2004 Oct; 61(4):466-72. PubMed ID: 15473879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum insulin-like growth factor-I, insulin-like growth factor binding proteins, and bone mineral content in hyperthyroidism.
    Lakatos P; Foldes J; Nagy Z; Takacs I; Speer G; Horvath C; Mohan S; Baylink DJ; Stern PH
    Thyroid; 2000 May; 10(5):417-23. PubMed ID: 10884189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased serum IGF-I and dehydroepiandrosterone sulphate may be risk factors for the development of reduced bone mass in postmenopausal women with endogenous subclinical hyperthyroidism.
    Földes J; Lakatos P; Zsadányi J; Horváth C
    Eur J Endocrinol; 1997 Mar; 136(3):277-81. PubMed ID: 9100552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal changes of bone density and bone resorption in hyperthyroid girls during treatment.
    Mora S; Weber G; Marenzi K; Signorini E; Rovelli R; Proverbio MC; Chiumello G
    J Bone Miner Res; 1999 Nov; 14(11):1971-7. PubMed ID: 10571698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal changes in lumbar bone density among thyrotoxic patients after attainment of euthyroidism.
    Rosen CJ; Adler RA
    J Clin Endocrinol Metab; 1992 Dec; 75(6):1531-4. PubMed ID: 1464660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Parathyroid function in hyperthyroidism: implications for bone metabolism and effect of the treatment].
    Furlanetto RP; Castro ML; de Mesquita CH; Kasamatsu TS; Vieira JG
    Rev Paul Med; 1991; 109(2):55-60. PubMed ID: 1909454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperthyroidism, bone mineral, and fracture risk--a meta-analysis.
    Vestergaard P; Mosekilde L
    Thyroid; 2003 Jun; 13(6):585-93. PubMed ID: 12930603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High serum osteoprotegerin levels in patients with hyperthyroidism: effect of medical treatment.
    Amato G; Mazziotti G; Sorvillo F; Piscopo M; Lalli E; Biondi B; Iorio S; Molinari A; Giustina A; Carella C
    Bone; 2004 Sep; 35(3):785-91. PubMed ID: 15336617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Change in bone mineral density in female patients with hyperthyroidism].
    Zhang H; Ye AL; Liao EY
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 May; 33(5):452-5. PubMed ID: 18544852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variable bone mass recovery in hyperthyroid bone disease after radioiodine therapy in postmenopausal patients.
    Obermayer-Pietsch B; Dobnig H; Warnkross H; Dimai HP; Weber K; Berghold A; Leb G
    Maturitas; 2000 May; 35(2):159-66. PubMed ID: 10924842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relative contributions of menopause and aging to postmenopausal vertebral osteopenia.
    Gambacciani M; Spinetti A; de Simone L; Cappagli B; Maffei S; Taponeco F; Fioretti P
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1148-51. PubMed ID: 8077305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism.
    Pantazi H; Papapetrou PD
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1099-106. PubMed ID: 10720046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Methimazole versus methimazole and diphosphonates in hyperthyroid and osteoporotic patients].
    Lupoli GA; Fittipaldi MR; Fonderico F; Panico A; Colarusso S; Di Micco L; Cavallo A; Costa L; Paglione A; Lupoli G
    Minerva Endocrinol; 2005 Jun; 30(2):89-94. PubMed ID: 15988404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males.
    Di Somma C; Colao A; Di Sarno A; Klain M; Landi ML; Facciolli G; Pivonello R; Panza N; Salvatore M; Lombardi G
    J Clin Endocrinol Metab; 1998 Mar; 83(3):807-13. PubMed ID: 9506732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of bone mineral density in hyperthyroid patients before and after medical therapy].
    Safi S; Hassikou H; Hadri L; Sbihi A; Kadiri A
    Ann Endocrinol (Paris); 2006 Mar; 67(1):27-31. PubMed ID: 16596054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.